N-α-Fmoc-N-δ-methyltrityl-D-lysine

N-α-Fmoc-N-δ-methyltrityl-D-lysine is an Fmoc-protected D-lysine derivative bearing an N-δ methyltrityl protecting group on the side-chain amine, creating a doubly protected amino acid suitable for orthogonal peptide chemistry. The molecule contains a chiral α-center characteristic of D-lysine, a carboxylate functionality masked as a non-reactive form appropriate for peptide coupling workflows, and a rigid aromatic trityl-based protecting group that suppresses side-chain reactivity during N-terminal assembly. The Fmoc group enables base-labile N-terminal deprotection, while the δ-methyltrityl group provides acid-stable, bulky protection that can be selectively removed to reveal the lysine side-chain for controlled functionalization. The combination of stereochemical definition and orthogonal protecting-group behavior makes this compound a chiral, protected amino acid intermediate for constructing lysine-containing peptides and for downstream derivatization of the ε-amine equivalent after side-chain unmasking.

1. Peptide Synthesis

N-α-Fmoc-N-δ-methyltrityl-D-lysine supports solid-phase peptide synthesis and solution-phase peptide coupling where lysine side-chain amine must remain masked during chain elongation. The Fmoc group governs N-terminal deprotection under base conditions, enabling sequential peptide bond formation while maintaining the D-lysine stereocenter throughout coupling. The δ-methyltrityl protection suppresses side-chain nucleophilicity during amide bond formation, reducing undesired branching, crosslinking, or intramolecular cyclization. After controlled side-chain deprotection, the revealed lysine amine can be carried forward into peptide analog construction, including charged residue placement and late-stage functionalization. The protected amino acid framework aligns with standard peptide building block preparation strategies used in synthetic peptide chemistry and applied peptide manufacturing.

2. Side-Chain Functionalization

N-α-Fmoc-N-δ-methyltrityl-D-lysine enables side-chain functionalization workflows that require orthogonal unveiling of the lysine ε-amine equivalent for conjugation or derivatization. The δ-methyltrityl group provides steric shielding and chemical stability during earlier synthetic steps, allowing the side-chain to be held in a protected state while the peptide backbone is assembled or modified at the N-terminus. Controlled removal of the δ protecting group can generate a reactive amine handle suitable for forming urea, amide, sulfonamide, or carbamate linkages, as well as for attaching electrophilic labels used in chemical biology. The presence of the Fmoc moiety further supports staged synthesis, where N-terminal deprotection and side-chain activation can be scheduled to match the desired order of modifications. This orthogonality supports downstream generation of functionalized lysine-containing peptides, peptidomimetics, and labeled biomolecule fragments.

3. Chemical Biology Labeling

N-α-Fmoc-N-δ-methyltrityl-D-lysine is applicable to chemical biology and biomolecule labeling schemes that require a defined, protected lysine residue for controlled conjugation chemistry. The protected side-chain amine enables incorporation of a lysine unit into peptide probes without premature reaction with activated esters, isothiocyanates, or other electrophiles that may be present in labeling mixtures. The D-lysine configuration can be used to tune peptide stereochemistry for probe stability and recognition studies, while the orthogonal protecting groups allow sequential unmasking to install labels at specific positions. Fmoc-mediated N-terminal control supports assembly of probe scaffolds where terminal modifications can be introduced after backbone construction. The resulting labeled peptide or peptide fragment can be used as an analytical or functional reagent in studies of molecular recognition, protein interactions, and targeted chemical tagging.

4. Peptidomimetics And SAR Studies

N-α-Fmoc-N-δ-methyltrityl-D-lysine supports peptidomimetic construction and structure-activity relationship studies requiring systematic variation of lysine-containing motifs. The protected lysine side-chain amine serves as a controllable functional element that can be converted into amide-linked substituents, cationic handles, or constrained derivatives after deprotection, enabling SAR-driven exploration of charge, spacing, and hydrogen-bonding patterns. The Fmoc group allows consistent incorporation into peptide-like backbones, while the δ-methyltrityl protection helps preserve side-chain integrity during iterative synthesis of analog libraries. The defined D stereochemistry provides a stereochemical handle for evaluating how inversion at the lysine α-center influences conformation and binding-related properties in peptide analog series. Downstream derivatives prepared from this chiral, protected intermediate can be used to generate focused analog panels for medicinal chemistry research and molecular design workflows.

5. Pharmaceutical Manufacturing Intermediate

N-α-Fmoc-N-δ-methyltrityl-D-lysine is suitable as a process-relevant intermediate for manufacturing lysine-containing peptides and peptide building blocks used in pharmaceutical-grade production workflows. The orthogonal protection strategy, combining base-labile Fmoc deprotection with a side-chain protecting group that withstands conditions used during earlier coupling steps, supports reproducible synthetic sequences and controlled impurity profiles associated with side-chain reactivity. The bulky trityl-derived δ protection can mitigate undesired side reactions during scale-up peptide assembly, while the defined D stereochemistry supports consistent stereochemical outcomes across batch production. The compound's protected amino acid format aligns with downstream conversion into peptide intermediates that can undergo further purification and subsequent functional-group transformations. This makes the material a practical chiral input for fine chemical synthesis and peptide manufacturing operations where robust protecting-group management is central to process design.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

3. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis